Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
Inhibin-a immunoreactivity in nervous system lesions.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Postural control, falls and fear of falling in people with multiple sclerosis without mobility aids.
Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population.
Television-provoked epilepsy in children: a follow-up survey from Isfahan, Iran.
Autoimmune neuropathies: insights from animal models.
Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
The crystal structure of an integral membrane fatty acid α-hydroxylase.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis.
Antiphospholipid antibodies: paradigm in transition.
Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.
New Developments in Murine Imaging for Assessing Photoreceptor Degeneration In Vivo.
A steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis.
Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology.
B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses.
Central remyelination restores secure conduction.
Pages
« first
‹ previous
…
711
712
713
714
715
716
717
718
719
…
next ›
last »